Tianfeng Securities gives Ketuo Bio a buy rating: probiotics business maintains a high growth trend, and R&D barriers are built to lead the industry

Post date April 29, 2022 — 12:40 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

The five major insurance companies increased their premiums by 3.46% in the first four months: the growth rate of property insurance slowed down, and the life insurance was differentiated

May 17, 2022 — 17:23

The five insurance companies' premiums increased by 3.46% in the first four months: property insurance growth slowed down and life insurance differentiation jqknews

May 17, 2022 — 17:22

Tianfeng Securities: Grasp the investment opportunities of mergers and acquisitions on the left side of the real estate industry and increased concentration on the right side

May 17, 2022 — 17:20

BNP Paribas may increase its stake in Bank of Nanjing

May 17, 2022 — 16:21

37 listed securities companies plan to distribute 57.746 billion yuan in dividends, an increase of 21% year-on-year. The dividend rate of these two securities companies exceeds 5%

May 17, 2022 — 14:34

37 listed securities companies plan to distribute 57.746 billion yuan in dividends, a year-on-year increase of 21%. The dividend rate of these two securities companies exceeds 5%! -Funds Financial Sector

May 17, 2022 — 12:50

Chenzhan Optoelectronics has been surveyed by 5 institutions: Up to now, production capacity and shipments are still at a high level (with survey questions and answers)

May 17, 2022 — 12:34

Neither Liu Hongshu nor Li Jiaqi, Xiaohongshu's "second-tier" community dilemma

May 17, 2022 — 10:08

Another case of "A buys A", Tongce Medical "huaguang" book funds to acquire Heren Technology

May 17, 2022 — 02:18

Home » News » Tianfeng Securities gives Ketuo Bio a buy rating: probiotics business maintains a high growth trend, and R&D barriers are built to lead the industry